Should You Increase the GLP1 Dose
Microneedles as a promising technology for disease monitoring and drug delivery: a review
Attorneys must possess detailed medical expertise about gastroparesis and NAION to fully represent injured clients: Gastroparesis pathophysiology, including how delayed gastric emptying affects digestion, nutrition, and overall health NAION mechanism of injury and why this optic nerve damage causes sudden, irreversible vision loss Treatment options for gastroparesis (dietary modifications, medications, feeding tubes) and their limitations Long-term health implications of stomach paralysis including malnutrition, aspiration risk, and reduced life expectancy Diagnostic procedures used to confirm gastroparesis and NAION, and how medical records document these medical issues Gastroparesis involves more than simple nausea or vomiting it represents a serious, often permanent condition where stomach muscles stop contracting properly, preventing food from moving into the small intestine
For neuroprotective mitochondria-targeted drugs with several systemic side effects, such as pitavastatin and pentoxifylline, intranasal drug administration could be a promising option to target the CNS using a lower dose that would minimize systemic exposure, thus decreasing the unwanted adverse systemic effects
A potential issue is that, with extended use of GLP-1 RAs, the body may develop resistance to the drugs effects
